The biochemistry of rapid replication
Replikins Logo

home
right
right
right
right
right
right
right
home

 

61. H7N9 Solid Phase Completely Synthetic Replikins Vaccine Ready for Testing to Prevent Possible Pandemic April 9, 2013


LONDON, April 9 -- Bioradar UK Ltd and Replikins Ltd announced today that a new completely synthetic H7N9 Replikins Vaccine is ready for testing. The news comes on the heels of four new cases of avian flu (H7N9) reported in China, bringing the total to 28 cases, 8 of whom have died from the virus.

The new vaccine is produced without any biological substances and will be used without adjuvants, similar to the H5N1 Synthetic Replikins Vaccine which was found effective (1).

Contact: sbogoch@replikins.com tel 646-320-5910

References

  1. Jackwood et al. Avian Diseases 53(4): 613-617, 2009
  2. Replikins.com

 

Learn more  

Dr. Sanjay Gupta of CNN reports on Replikins

Synthetic flu vaccine option?

2009 report on Replikins and the potential of synthetic vaccine technology to improve on traditional vaccine approaches.